Expansion of B10 cells in vitro: Pathways, techniques and applications in transplantation (Review)
- Authors:
- Dayue Zhao
- Guoli Huai
- Yuan Yuan
- Yuanyuan Cui
- Yinglin Yuan
- Gaoping Zhao
-
Affiliations: Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, P.R. China, Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, P.R. China - Published online on: December 10, 2024 https://doi.org/10.3892/ijmm.2024.5470
- Article Number: 29
-
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Neu SD and Dittel BN: Characterization of definitive regulatory B cell subsets by cell surface phenotype, function and context. Front Immunol. 12:7874642021. View Article : Google Scholar | |
Mohib K, Cherukuri A, Zhou Y, Ding Q, Watkins SC and Rothstein DM: Antigen-dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCs. Am J Transplant. 20:52–63. 2020. View Article : Google Scholar | |
Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A and Fallon PG: Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol. 125:1114–1124.e8. 2010. View Article : Google Scholar : PubMed/NCBI | |
Vomhof-DeKrey EE, Yates J, Hägglöf T, Lanthier P, Amiel E, Veerapen N, Besra GS, Karlsson MC and Leadbetter EA: Cognate interaction with iNKT cells expands IL-10-producing B regulatory cells. Proc Natl Acad Sci USA. 112:12474–12479. 2015. View Article : Google Scholar : PubMed/NCBI | |
Boldison J, Da Rosa LC, Davies J, Wen L and Wong FS: Dendritic cells license regulatory B cells to produce IL-10 and mediate suppression of antigen-specific CD8 T cells. Cell Mol Immunol. 17:843–855. 2020. View Article : Google Scholar : | |
Geladaris A, Häusser-Kinzel S, Pretzsch R, Nissimov N, Lehmann-Horn K, Häusler D and Weber MS: IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity. Acta Neuropathol. 145:461–477. 2023. View Article : Google Scholar : PubMed/NCBI | |
Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M and Tedder TF: A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 28:639–650. 2008. View Article : Google Scholar : PubMed/NCBI | |
Rosser EC and Mauri C: Regulatory B cells: Origin, phenotype, and function. Immunity. 42:607–612. 2015. View Article : Google Scholar : PubMed/NCBI | |
Shang J, Zha H and Sun Y: Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer. Front Immunol. 11:5826572020. View Article : Google Scholar : PubMed/NCBI | |
Hong J, Fang J, Lan R, Tan Q, Tian Y, Zhang M, Okunieff P, Zhang L, Lin J and Han D: TLR9 mediated regulatory B10 cell amplification following sub-total body irradiation: Implications in attenuating EAE. Mol Immunol. 83:52–61. 2017. View Article : Google Scholar : PubMed/NCBI | |
Zheremyan EA, Ustiugova AS, Karamushka NM, Uvarova AN, Stasevich EM, Bogolyubova AV, Kuprash DV and Korneev KV: Breg-Mediated Immunoregulation in the Skin. Int J Mol Sci. 25:5832024. View Article : Google Scholar : PubMed/NCBI | |
Mauri C and Menon M: Human regulatory B cells in health and disease: therapeutic potential. J Clin Invest. 127:772–779. 2017. View Article : Google Scholar : PubMed/NCBI | |
Yu CR, Choi JK, Uche AN and Egwuagu CE: Production of IL-35 by Bregs is mediated through binding of BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements. J Leukoc Biol. 104:1147–1157. 2018. View Article : Google Scholar : PubMed/NCBI | |
Oleinika K, Mauri C and Salama AD: Effector and regulatory B cells in immune-mediated kidney disease. Nat Rev Nephrol. 15:11–26. 2019. View Article : Google Scholar | |
Elias C, Chen C and Cherukuri A: Regulatory B cells in solid organ transplantation: From immune monitoring to immunotherapy. Transplantation. 108:1080–1089. 2024. | |
Juneja T, Kazmi M, Mellace M and Saidi RF: Utilization of Treg Cells in Solid Organ Transplantation. Front Immunol. 13:7468892022. View Article : Google Scholar : PubMed/NCBI | |
Kessel A, Haj T, Peri R, Snir A, Melamed D, Sabo E and Toubi E: Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun Rev. 11:670–677. 2012. View Article : Google Scholar | |
Lee KM, Stott RT, Zhao G, SooHoo J, Xiong W, Lian MM, Fitzgerald L, Shi S, Akrawi E, Lei J, et al: TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. Eur J Immunol. 44:1728–1736. 2014. View Article : Google Scholar : PubMed/NCBI | |
Deng S, Moore DJ, Huang X, Lian MM, Mohiuddin M, Velededeoglu E, Lee MK IV, Sonawane S, Kim J, Wang J, et al: Cutting edge: Transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol. 178:6028–6032. 2007. View Article : Google Scholar : PubMed/NCBI | |
Singh A, Carson WF IV, Secor ER Jr, Guernsey LA, Flavell RA, Clark RB, Thrall RS and Schramm CM: Regulatory role of B cells in a murine model of allergic airway disease. J Immunol. 180:7318–7326. 2008. View Article : Google Scholar : PubMed/NCBI | |
Zhao G, Moore DJ, Lee KM, Kim JI, Duff PE, O'Connor MR, Hirohashi T, Lei J, Yang M, Markmann JF and Deng S: An unexpected counter-regulatory role of IL-10 in B-lymphocyte-mediated transplantation tolerance. Am J Transplant. 10:796–801. 2010. View Article : Google Scholar : PubMed/NCBI | |
Lal G, Nakayama Y, Sethi A, Singh AK, Burrell BE, Kulkarni N, Brinkman CC, Iwami D, Zhang T and Bromberg JS: Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance. Transplantation. 99:1817–1828. 2015. View Article : Google Scholar : PubMed/NCBI | |
Fillatreau S, Gray D and Anderton SM: Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol. 8:391–397. 2008. View Article : Google Scholar : PubMed/NCBI | |
Anderton SM and Fillatreau S: Activated B cells in autoimmune diseases: the case for a regulatory role. Nat Clin Pract Rheumatol. 4:657–666. 2008. View Article : Google Scholar : PubMed/NCBI | |
Lanzavecchia A and Sallusto F: Toll-like receptors and innate immunity in B-cell activation and antibody responses. Curr Opin Immunol. 19:268–274. 2007. View Article : Google Scholar : PubMed/NCBI | |
Zindel J and Kubes P: DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation. Annu Rev Pathol. 15:493–518. 2020. View Article : Google Scholar | |
Romani L: Immunity to fungal infections. Nat Rev Immunol. 11:275–288. 2011. View Article : Google Scholar : PubMed/NCBI | |
Kumar V and Sharma A: Innate immunity in sepsis pathogenesis and its modulation: New immunomodulatory targets revealed. J Chemother. 20:672–683. 2008. View Article : Google Scholar | |
Iwasaki A and Medzhitov R: Regulation of adaptive immunity by the innate immune system. Science. 327:291–295. 2010. View Article : Google Scholar : PubMed/NCBI | |
Sîrbulescu RF, Mamidi A, Chan SY, Jin G, Boukhali M, Sobell D, Ilieş I, Chung JY, Haas W, Whalen MJ, et al: B cells support the repair of injured tissues by adopting MyD88-dependent regulatory functions and phenotype. FASEB J. 35:e220192021. View Article : Google Scholar : PubMed/NCBI | |
Xu Y, Wu K, Han S, Ding S, Lu G, Lin Z, Zhang Y, Xiao W, Gong W, Ding Y and Deng B: Astilbin combined with lipopolysaccharide induces IL-10-producing regulatory B cells via the STAT3 signalling pathway. Biomed Pharmacother. 129:1104502020. View Article : Google Scholar : PubMed/NCBI | |
Lampropoulou V, Hoehlig K, Roch T, Neves P, Calderón Gómez E, Sweenie CH, Hao Y, Freitas AA, Steinhoff U, Anderton SM and Fillatreau S: TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol. 180:4763–4773. 2008. View Article : Google Scholar : PubMed/NCBI | |
Liu BS, Cao Y, Huizinga TW, Hafler DA and Toes RE: TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells. Eur J Immunol. 44:2121–2129. 2014. View Article : Google Scholar : PubMed/NCBI | |
Kawai T and Akira S: The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 11:373–384. 2010. View Article : Google Scholar : PubMed/NCBI | |
Pasare C and Medzhitov R: Control of B-cell responses by Toll-like receptors. Nature. 438:364–368. 2005. View Article : Google Scholar : PubMed/NCBI | |
Yoshizaki A, Miyagaki T, DiLillo DJ, Matsushita T, Horikawa M, Kountikov EI, Spolski R, Poe JC, Leonard WJ and Tedder TF: Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 491:264–268. 2012. View Article : Google Scholar : PubMed/NCBI | |
Barr TA, Brown S, Ryan G, Zhao J and Gray D: TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur J Immunol. 37:3040–3053. 2007. View Article : Google Scholar : PubMed/NCBI | |
Hao Y, O'Neill P, Naradikian MS, Scholz JL and Cancro MP: A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood. 118:1294–1304. 2011. View Article : Google Scholar : PubMed/NCBI | |
Takeda K and Akira S: TLR signaling pathways. Semin Immunol. 16:3–9. 2004. View Article : Google Scholar : PubMed/NCBI | |
Tian F, Xian K, Yang B, Duan Q, Qian L and Shi C: Deficiency in TLR4 impairs regulatory B cells production induced by Schistosome soluble egg antigen. Mol Biochem Parasitol. 253:1115322023. View Article : Google Scholar | |
Oladipupo FO, Yu CR, Olumuyide E, Jittaysothorn Y, Choi JK and Egwuagu CE: STAT3 deficiency in B cells exacerbates uveitis by promoting expansion of pathogenic lymphocytes and suppressing regulatory B cells (Bregs) and Tregs. Sci Rep. 10:161882020. View Article : Google Scholar : PubMed/NCBI | |
Shankar S, Stolp J, Juvet SC, Beckett J, Macklin PS, Issa F, Hester J and Wood KJ: Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis. Nat Commun. 13:31212022. View Article : Google Scholar : | |
Bauer S, Kirschning CJ, Häcker H, Redecke V, Hausmann S, Akira S, Wagner H and Lipford GB: Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA. 98:9237–9242. 2001. View Article : Google Scholar : PubMed/NCBI | |
Ohto U, Shibata T, Tanji H, Ishida H, Krayukhina E, Uchiyama S, Miyake K and Shimizu T: Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9. Nature. 520:702–705. 2015. View Article : Google Scholar : PubMed/NCBI | |
Akkaya M, Akkaya B, Kim AS, Miozzo P, Sohn H, Pena M, Roesler AS, Theall BP, Henke T, Kabat J, et al: Toll-like receptor 9 antagonizes antibody affinity maturation. Nat Immunol. 19:255–266. 2018. View Article : Google Scholar : PubMed/NCBI | |
Alaqla A, Hu Y, Huang S, Ruiz S, Kawai T and Han X: TLR9 signaling is required for the porphyromonas gingivalis-induced activation of IL-10-expressing B cells. Int J Mol Sci. 24:66932023. View Article : Google Scholar : PubMed/NCBI | |
Ohto U and Shimizu T: Structural aspects of nucleic acid-sensing Toll-like receptors. Biophys Rev. 8:33–43. 2016. View Article : Google Scholar : PubMed/NCBI | |
Hu Q, Li H, Wang L, Gu H and Fan C: DNA Nanotechnology-Enabled drug delivery systems. Chem Rev. 119:6459–6506. 2019. View Article : Google Scholar | |
Mutwiri G, van Drunen Littel-van den Hurk S and Babiuk LA: Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides. Adv Drug Deliv Rev. 61:226–232. 2009. View Article : Google Scholar : PubMed/NCBI | |
Kawai T and Akira S: Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 13:460–469. 2007. View Article : Google Scholar : PubMed/NCBI | |
Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, Takeshita F, Matsuda M, Coban C, Ishii KJ, Kawai T, et al: Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J Exp Med. 201:915–923. 2005. View Article : Google Scholar : PubMed/NCBI | |
Walsh MC, Lee J and Choi Y: Tumor necrosis factor receptor-associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol Rev. 266:72–92. 2015. View Article : Google Scholar : PubMed/NCBI | |
O'Neill LA and Bowie AG: The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol. 7:353–364. 2007. View Article : Google Scholar : PubMed/NCBI | |
Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O and Akira S: Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol. 6:1087–1095. 2005. View Article : Google Scholar : PubMed/NCBI | |
Yang M, Sun L, Wang S, Ko KH, Xu H, Zheng BJ, Cao X and Lu L: Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol. 184:3321–3325. 2010. View Article : Google Scholar : PubMed/NCBI | |
Huang X and Yang Y: Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses. Expert Opin Ther Targets. 14:787–796. 2010. View Article : Google Scholar : PubMed/NCBI | |
Honke N, Lowin T, Opgenoorth B, Shaabani N, Lautwein A, Teijaro JR, Schneider M and Pongratz G: Endogenously produced catecholamines improve the regulatory function of TLR9-activated B cells. PLoS Biol. 20:e30015132022. View Article : Google Scholar : PubMed/NCBI | |
Pongratz G, Melzer M and Straub RH: The sympathetic nervous system stimulates anti-inflammatory B cells in collagen-type II-induced arthritis. Ann Rheum Dis. 71:432–439. 2012. View Article : Google Scholar | |
Darnell JE Jr: STATs and gene regulation. Science. 277:1630–1635. 1997. View Article : Google Scholar : PubMed/NCBI | |
Levy DE and Darnell JE Jr: Stats: Transcriptional control and biological impact. Nat Rev Mol Cell Biol. 3:651–662. 2002. View Article : Google Scholar : PubMed/NCBI | |
Bromberg J: Stat proteins and oncogenesis. J Clin Invest. 109:1139–1142. 2002. View Article : Google Scholar : PubMed/NCBI | |
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell JE Jr: Stat3 as an oncogene. Cell. 98:295–303. 1999. View Article : Google Scholar : PubMed/NCBI | |
Wang YH, Tsai DY, Ko YA, Yang TT, Lin IY, Hung KH and Lin KI: Blimp-1 Contributes to the Development and Function of Regulatory B Cells. Front Immunol. 10:19092019. View Article : Google Scholar : PubMed/NCBI | |
Diehl SA, Schmidlin H, Nagasawa M, van Haren SD, Kwakkenbos MJ, Yasuda E, Beaumont T, Scheeren FA and Spits H: STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J Immunol. 180:4805–4815. 2008. View Article : Google Scholar : PubMed/NCBI | |
Michée-Cospolite M, Boudigou M, Grasseau A, Simon Q, Mignen O, Pers JO, Cornec D, Le Pottier L and Hillion S: Molecular Mechanisms Driving IL-10- Producing B Cells Functions: STAT3 and c-MAF as Underestimated Central Key Regulators? Front Immunol. 13:8188142022. View Article : Google Scholar : PubMed/NCBI | |
Jin G, Hamaguchi Y, Matsushita T, Hasegawa M, Le Huu D, Ishiura N, Naka K, Hirao A, Takehara K and Fujimoto M: B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. J Allergy Clin Immunol. 131:1674–1682. 2013. View Article : Google Scholar : PubMed/NCBI | |
Zhou M, Wen Z, Cheng F, Ma J, Li W, Ren H, Sheng Y, Dong H, Lu L, Hu HM and Wang LX: Tumor-released autophagosomes induce IL-10-producing B cells with suppressive activity on T lymphocytes via TLR2-MyD88-NF-κB signal pathway. Oncoimmunology. 5:e11804852016. View Article : Google Scholar | |
Wang K, Tao L, Su J, Zhang Y, Zou B, Wang Y, Zou M, Chen N, Lei L and Li X: TLR4 supports the expansion of FasL + CD5 + CD1d hi regulatory B cells, which decreases in contact hypersensitivity. Mol Immunol. 87:188–199. 2017. View Article : Google Scholar : PubMed/NCBI | |
Lee MB, Lee JH, Hong SH, You JS, Nam ST, Kim HW, Park YH, Lee D, Min KY, Park YM, et al: JQ1, a BET inhibitor, controls TLR4-induced IL-10 production in regulatory B cells by BRD4-NF-κB axis. BMB Rep. 50:640–646. 2017. View Article : Google Scholar : PubMed/NCBI | |
Pore D, Matsui K, Parameswaran N and Gupta N: Cutting Edge: Ezrin Regulates Inflammation by Limiting B Cell IL-10 Production. J Immunol. 196:558–562. 2016. View Article : Google Scholar | |
Mishima Y, Oka A, Liu B, Herzog JW, Eun CS, Fan TJ, Bulik-Sullivan E, Carroll IM, Hansen JJ, Chen L, et al: Microbiota maintain colonic homeostasis by activating TLR2/MyD88/PI3K signaling in IL-10-producing regulatory B cells. J Clin Invest. 129:3702–3716. 2019. View Article : Google Scholar : PubMed/NCBI | |
Lanzavecchia A: Antigen-specific interaction between T and B cells. Nature. 314:537–539. 1985. View Article : Google Scholar : PubMed/NCBI | |
Clark MR, Campbell KS, Kazlauskas A, Johnson SA, Hertz M, Potter TA, Pleiman C and Cambier JC: The B cell antigen receptor complex: Association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors. Science. 258:123–126. 1992. View Article : Google Scholar : PubMed/NCBI | |
Reth M: Antigen receptor tail clue. Nature. 338:383–384. 1989. View Article : Google Scholar : PubMed/NCBI | |
Niiro H and Clark EA: Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol. 2:945–956. 2002. View Article : Google Scholar : PubMed/NCBI | |
Dal Porto JM, Gauld SB, Merrell KT, Mills D, Pugh-Bernard AE and Cambier J: B cell antigen receptor signaling 101. Mol Immunol. 41:599–613. 2004. View Article : Google Scholar : PubMed/NCBI | |
Saijo K, Schmedt C, Su IH, Karasuyama H, Lowell CA, Reth M, Adachi T, Patke A, Santana A and Tarakhovsky A: Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development. Nat Immunol. 4:274–279. 2003. View Article : Google Scholar : PubMed/NCBI | |
Carter RH and Fearon DT: CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 256:105–107. 1992. View Article : Google Scholar : PubMed/NCBI | |
Baracho GV, Miletic AV, Omori SA, Cato MH and Rickert RC: Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation. Curr Opin Immunol. 23:178–183. 2011. View Article : Google Scholar : PubMed/NCBI | |
Fujimoto M, Fujimoto Y, Poe JC, Jansen PJ, Lowell CA, DeFranco AL and Tedder TF: CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity. 13:47–57. 2000. View Article : Google Scholar : PubMed/NCBI | |
Gold MR, Law DA and DeFranco AL: Stimulation of protein tyrosine phosphorylation by the B-lymphocyte antigen receptor. Nature. 345:810–813. 1990. View Article : Google Scholar : PubMed/NCBI | |
Fillatreau S, Sweenie CH, McGeachy MJ, Gray D and Anderton SM: B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 3:944–950. 2002. View Article : Google Scholar : PubMed/NCBI | |
Yanaba K, Bouaziz JD, Matsushita T, Tsubata T and Tedder TF: The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol. 182:7459–7472. 2009. View Article : Google Scholar : PubMed/NCBI | |
Hussain S and Delovitch TL: Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J Immunol. 179:7225–7232. 2007. View Article : Google Scholar : PubMed/NCBI | |
Adori M, Khoenkhoen S, Zhang J, Dopico XC and Karlsson Hedestam GB: Enhanced B Cell Receptor Signaling Partially Compensates for Impaired Toll-like Receptor 4 Responses in LPS-Stimulated IκBNS-Deficient B Cells. Cells. 12:12292023. View Article : Google Scholar | |
Tedder TF: B10 cells: A functionally defined regulatory B cell subset. J Immunol. 194:1395–1401. 2015. View Article : Google Scholar : PubMed/NCBI | |
Parekh VV, Prasad DVR, Banerjee PP, Joshi BN, Kumar A and Mishra GC: B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: role of TGF-beta 1. J Immunol. 170:5897–5911. 2003. View Article : Google Scholar : PubMed/NCBI | |
Hazeki K, Nigorikawa K and Hazeki O: Role of phosphoinositide 3-kinase in innate immunity. Biol Pharm Bull. 30:1617–1723. 2007. View Article : Google Scholar : PubMed/NCBI | |
Ruse M and Knaus UG: New players in TLR-mediated innate immunity: PI3K and small Rho GTPases. Immunol Res. 34:33–48. 2006. View Article : Google Scholar : PubMed/NCBI | |
Tuveson DA, Carter RH, Soltoff SP and Fearon DT: CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science. 260:986–989. 1993. View Article : Google Scholar : PubMed/NCBI | |
Ingham RJ, Holgado-Madruga M, Siu C, Wong AJ and Gold MR: The Gab1 protein is a docking site for multiple proteins involved in signaling by the B cell antigen receptor. J Biol Chem. 273:30630–30637. 1998. View Article : Google Scholar : PubMed/NCBI | |
Okada T, Maeda A, Iwamatsu A, Gotoh K and Kurosaki T: BCAP: The tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity. 13:817–827. 2000. View Article : Google Scholar | |
Panchamoorthy G, Fukazawa T, Miyake S, Soltoff S, Reedquist K, Druker B, Shoelson S, Cantley L and Band H: p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem. 271:3187–3194. 1996. View Article : Google Scholar : PubMed/NCBI | |
Gold MR: Intermediary signaling effectors coupling the B-cell receptor to the nucleus. Curr Top Microbiol Immunol. 245:77–134. 2000. | |
Marshall AJ, Niiro H, Yun TJ and Clark EA: Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cgamma pathway. Immunol Rev. 176:30–46. 2000. View Article : Google Scholar : PubMed/NCBI | |
Lemmon MA and Ferguson KM: Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem J. 350 Pt 1(Pt 1): 1–18. 2000.PubMed/NCBI | |
Scheid MP and Woodgett JR: PKB/AKT: Functional insights from genetic models. Nat Rev Mol Cell Biol. 2:760–768. 2001. View Article : Google Scholar : PubMed/NCBI | |
Cross DA, Alessi DR, Cohen P, Andjelkovich M and Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:785–789. 1995. View Article : Google Scholar : PubMed/NCBI | |
Li J, Gao J, Zhou H, Zhou J, Deng Z, Lu Y, Rao J, Ji G, Gu J, Yang X, et al: Inhibition of glycogen synthase kinase 3β increases the proportion and suppressive function of CD19+CD24hiCD27+ breg cells. Front Immunol. 11:6032882020. View Article : Google Scholar | |
Kaidanovich-Beilin O and Woodgett JR: GSK-3: Functional insights from cell biology and animal models. Front Mol Neurosci. 4:402011. View Article : Google Scholar : PubMed/NCBI | |
Maurer U, Preiss F, Brauns-Schubert P, Schlicher L and Charvet C: GSK-3 - at the crossroads of cell death and survival. J Cell Sci. 127(Pt 7): 1369–1378. 2014. View Article : Google Scholar : PubMed/NCBI | |
Gold MR, Scheid MP, Santos L, Dang-Lawson M, Roth RA, Matsuuchi L, Duronio V and Krebs DL: The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase. J Immunol. 163:1894–1905. 1999. View Article : Google Scholar : PubMed/NCBI | |
Cheng H, Wang L, Yang B, Li D, Wang X, Liu X, Tian N, Huang Q, Feng R, Wang Z, et al: Cutting edge: Inhibition of glycogen synthase kinase 3 activity induces the generation and enhanced suppressive function of human IL-10+ FOXP3+-induced regulatory T Cells. J Immunol. 205:1497–1502. 2020. View Article : Google Scholar : PubMed/NCBI | |
Mielle J, Morel J, Elhmioui J, Combe B, Macia L, Dardalhon V, Taylor N, Audo R and Daien C: Glutamine promotes the generation of B10+ cells via the mTOR/GSK3 pathway. Eur J Immunol. 52:418–430. 2022. View Article : Google Scholar | |
Chen Z and Wang JH: How the signaling crosstalk of B cell receptor (BCR) and Co-receptors regulates antibody class switch recombination: A new perspective of checkpoints of BCR signaling. Front Immunol. 12:6634432021. View Article : Google Scholar : PubMed/NCBI | |
Tsubata T, Wu J and Honjo T: B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature. 364:645–648. 1993. View Article : Google Scholar : PubMed/NCBI | |
Xu J, Foy TM, Laman JD, Elliott EA, Dunn JJ, Waldschmidt TJ, Elsemore J, Noelle RJ and Flavell RA: Mice deficient for the CD40 ligand. Immunity. 1:423–431. 1994. View Article : Google Scholar : PubMed/NCBI | |
Wang SP, Iwata S, Nakayamada S, Niiro H, Jabbarzadeh-Tabrizi S, Kondo M, Kubo S, Yoshikawa M and Tanaka Y: Amplification of IL-21 signalling pathway through Bruton's tyrosine kinase in human B cell activation. Rheumatology (Oxford). 54:1488–1497. 2015. View Article : Google Scholar : PubMed/NCBI | |
Bishop GA and Hostager BS: Signaling by CD40 and its mimics in B cell activation. Immunol Res. 24:97–109. 2001. View Article : Google Scholar : PubMed/NCBI | |
Poe JC, Smith SH, Haas KM, Yanaba K, Tsubata T, Matsushita T and Tedder TF: Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS One. 6:e224642011. View Article : Google Scholar : PubMed/NCBI | |
Chen C, Ma J, Pi C, Huang W, Zhang T, Fu C, Liu W and Yang YG: PPARδ inhibition blocks the induction and function of tumor-induced IL-10+ regulatory B cells and enhances cancer immunotherapy. Cell Discov. 9:542023. View Article : Google Scholar | |
Durand J, Huchet V, Merieau E, Usal C, Chesneau M, Remy S, Heslan M, Anegon I, Cuturi MC, Brouard S and Chiffoleau E: Regulatory B cells with a partial defect in CD40 signaling and overexpressing granzyme B transfer allograft tolerance in rodents. J Immunol. 195:5035–5044. 2015. View Article : Google Scholar : PubMed/NCBI | |
Jansen K, Cevhertas L, Ma S, Satitsuksanoa P, Akdis M and Van De Veen W: Regulatory B cells, A to Z. Allergy. 76:2699–2715. 2021. View Article : Google Scholar : PubMed/NCBI | |
Fu Q, Lee KM, Huai G, Deng K, Agarwal D, Rickert CG, Feeney N, Matheson R, Yang H, LeGuern C, et al: Properties of regulatory B cells regulating B cell targets. Am J Transplant. 21:3847–3857. 2021. View Article : Google Scholar : PubMed/NCBI | |
Matsumoto M, Baba A, Yokota T, Nishikawa H, Ohkawa Y, Kayama H, Kallies A, Nutt SL, Sakaguchi S, Takeda K, et al: Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity. 41:1040–1051. 2014. View Article : Google Scholar : PubMed/NCBI | |
Baba Y, Matsumoto M and Kurosaki T: Signals controlling the development and activity of regulatory B-lineage cells. Int Immunol. 27:487–493. 2015. View Article : Google Scholar : PubMed/NCBI | |
Bankó Z, Pozsgay J, Szili D, Tóth M, Gáti T, Nagy G, Rojkovich B and Sármay G: Induction and differentiation of IL-10-producing regulatory B cells from healthy blood donors and rheumatoid arthritis patients. J Immunol. 198:1512–1520. 2017. View Article : Google Scholar : PubMed/NCBI | |
Inaba A, Tuong ZK, Zhao TX, Stewart AP, Mathews R, Truman L, Sriranjan R, Kennet J, Saeb-Parsy K, Wicker L, et al: Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells. Nat Commun. 14:20712023. View Article : Google Scholar : PubMed/NCBI | |
Rosser EC, Oleinika K, Tonon S, Doyle R, Bosma A, Carter NA, Harris KA, Jones SA, Klein N and Mauri C: Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production. Nat Med. 20:1334–1339. 2014. View Article : Google Scholar : PubMed/NCBI | |
Liu X, Huang H, Gao H, Wu X, Zhang W, Yu B and Dou X: Regulatory B cells induced by ultraviolet B through toll-like receptor 4 signalling contribute to the suppression of contact hypersensitivity responses in mice. Contact Dermatitis. 78:117–130. 2018. View Article : Google Scholar | |
Poe JC, Haas KM, Uchida J, Lee Y, Fujimoto M and Tedder TF: Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background. J Immunol. 172:2100–2110. 2004. View Article : Google Scholar : PubMed/NCBI | |
Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, Szabolcs PM, Bernstein SH, Magro CM, Williams AD, et al: Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 117:530–541. 2011. View Article : Google Scholar : | |
Li X, Zhong H, Bao W, Boulad N, Evangelista J, Haider MA, Bussel J and Yazdanbakhsh K: Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood. 120:3318–3325. 2012. View Article : Google Scholar : PubMed/NCBI | |
Khoder A, Sarvaria A, Alsuliman A, Chew C, Sekine T, Cooper N, Mielke S, de Lavallade H, Muftuoglu M, Fernandez Curbelo I, et al: Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD. Blood. 124:2034–2045. 2014. View Article : Google Scholar : PubMed/NCBI | |
Lee KM, Fu Q, Huai G, Deng K, Lei J, Kojima L, Agarwal D, van Galen P, Kimura S, Tanimine N, et al: Suppression of allograft rejection by regulatory B cells induced via TLR signaling. JCI Insight. 7:e1522132022. View Article : Google Scholar : PubMed/NCBI | |
Veh J, Mangold C, Felsen A, Ludwig C, Gerstner L, Reinhardt P, Schrezenmeier H, Fabricius D and Jahrsdörfer B: Phorbol-12-myristate-13-acetate is a potent enhancer of B cells with a granzyme B+ regulatory phenotype. Front Immunol. 14:11948802023. View Article : Google Scholar : | |
Han Y, Yu C, Yu Y and Bi L: CD25+ B cells produced IL-35 and alleviated local inflammation during experimental periodontitis. Oral Dis. 28:2248–2257. 2022. View Article : Google Scholar | |
Zeng R, Spolski R, Casas E, Zhu W, Levy DE and Leonard WJ: The molecular basis of IL-21-mediated proliferation. Blood. 109:4135–4142. 2007. View Article : Google Scholar : PubMed/NCBI | |
Zheremyan EA, Ustiugova AS, Uvarova AN, Karamushka NM, Stasevich EM, Gogoleva VS, Bogolyubova AV, Mitkin NA, Kuprash DV and Korneev KV: Differentially activated B cells develop regulatory phenotype and show varying immunosuppressive features: A comparative study. Front Immunol. 14:11784452023. View Article : Google Scholar : PubMed/NCBI | |
Chesneau M, Mai HL, Danger R, Le Bot S, Nguyen TV, Bernard J, Poullaouec C, Guerrif P, Conchon S, Giral M, et al: Efficient expansion of human granzyme B-expressing B cells with potent regulatory properties. J Immunol. 205:2391–2401. 2020. View Article : Google Scholar : PubMed/NCBI | |
Thompson R and Cao X: Reassessing granzyme B: Unveiling perforin-independent versatility in immune responses and therapeutic potentials. Front Immunol. 15:13925352024. View Article : Google Scholar : PubMed/NCBI | |
Menon M, Blair PA, Isenberg DA and Mauri C: A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus. Immunity. 44:683–697. 2016. View Article : Google Scholar : PubMed/NCBI | |
Mohib K, Rothstein DM and Ding Q: Characterization and activity of TIM-1 and IL-10-reporter expressing regulatory B cells. Methods Mol Biol. 2270:179–202. 2021. View Article : Google Scholar : PubMed/NCBI | |
Carvajal Alegria G, Cornec D, Saraux A, Devauchelle-Pensec V, Jamin C, Hillion S and Pochard P: Abatacept promotes regulatory B cell functions, enhancing their ability to reduce the Th1 response in rheumatoid arthritis patients through the production of IL-10 and TGF-β. J Immunol. 207:470–482. 2021. View Article : Google Scholar : PubMed/NCBI | |
Song J, Xiao L, Du G, Gao Y, Chen W, Yang S, Fan W and Shi B: The role of regulatory B cells (Bregs) in the Tregs-amplifying effect of Sirolimus. Int Immunopharmacol. 38:90–96. 2016. View Article : Google Scholar : PubMed/NCBI | |
Wu M, Yu S, Chen Y, Meng W, Chen H, He J, Shen J and Lin X: Acteoside promotes B cell-derived IL-10 production and ameliorates autoimmunity. J Leukoc Biol. 112:875–885. 2022. View Article : Google Scholar : PubMed/NCBI | |
Mielle J, Audo R, Hahne M, Macia L, Combe B, Morel J and Daien C: IL-10 producing B cells ability to induce regulatory T cells is maintained in rheumatoid arthritis. Front Immunol. 9:9612018. View Article : Google Scholar : PubMed/NCBI | |
Goretzki A, Lin YJ, Meier C, Dorn B, Wolfheimer S, Jamin A, Schott M, Wangorsch A, Vieths S, Jakob T, et al: Stimulation of naïve B cells with a fusion protein consisting of FlaA and Bet v 1 induces regulatory B cells ex vivo. Allergy. 78:663–681. 2023. View Article : Google Scholar | |
Giacomini E, Rizzo F, Etna MP, Cruciani M, Mechelli R, Buscarinu MC, Pica F, D'Agostini C, Salvetti M, Coccia EM and Severa M: Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients. Mult Scler. 24:127–139. 2018. View Article : Google Scholar | |
Li W, Wang D, Yue R, Chen X, Liu A, Xu H, Teng P, Wang Z, Zou Y, Xu X, et al: Gut microbes enlarged the protective effect of transplanted regulatory B cells on rejection of cardiac allografts. J Heart Lung Transplant. 40:1502–1516. 2021. View Article : Google Scholar : PubMed/NCBI | |
Liao W, Xiao H, He J, Huang L, Liao Y, Qin J, Yang Q, Ma F and Li S: B-Cell-activating factor contributes to elevation of the content of regulatory B cells in neonatal sepsis. Bull Exp Biol Med. 175:72–77. 2023. View Article : Google Scholar : PubMed/NCBI | |
Saulep-Easton D, Vincent FB, Quah PS, Wei A, Ting SB, Croce CM, Tam C and Mackay F: The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia. 30:163–172. 2016. View Article : Google Scholar | |
Hua C, Audo R, Yeremenko N, Baeten D, Hahne M, Combe B, Morel J and Daïen C: A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cells. J Autoimmun. 73:64–72. 2016. View Article : Google Scholar : PubMed/NCBI | |
Fehres CM, van Uden NO, Yeremenko NG, Fernandez L, Franco Salinas G, van Duivenvoorde LM, Huard B, Morel J, Spits H, Hahne M and Baeten DLP: APRIL induces a novel subset of IgA+ regulatory B cells that suppress inflammation via expression of IL-10 and PD-L1. Front Immunol. 10:13682019. View Article : Google Scholar : | |
Planelles L, Carvalho-Pinto CE, Hardenberg G, Smaniotto S, Savino W, Gómez-Caro R, Alvarez-Mon M, de Jong J, Eldering E, Martínez-A C, et al: APRIL promotes B-1 cell-associated neoplasm. Cancer Cell. 6:399–408. 2004. View Article : Google Scholar : PubMed/NCBI | |
Zhang Y, Li J, Zhou N, Zhang Y, Wu M, Xu J, Shen C, An X, Shen G, Yang M, et al: The unknown aspect of BAFF: Inducing IL-35 production by a CD5+CD1dhiFcγRIIbhi regulatory B-cell subset in lupus. J Invest Dermatol. 137:2532–2543. 2017. View Article : Google Scholar : PubMed/NCBI | |
den Hartog G, van Osch TLJ, Vos M, Meijer B, Savelkoul HFJ, van Neerven RJJ and Brugman S: BAFF augments IgA2 and IL-10 production by TLR7/8 stimulated total peripheral blood B cells. Eur J Immunol. 48:283–292. 2018. View Article : Google Scholar | |
Komlósi ZI, Kovács N, van de Veen W, Kirsch AI, Fahrner HB, Wawrzyniak M, Rebane A, Stanic B, Palomares O, Rückert B, et al: Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells. J Allergy Clin Immunol. 142:178–194.e11. 2018. View Article : Google Scholar | |
Mu Y, Xu W, Liu J, Wang Y, Chen J and Zhou Q: Mesenchymal stem cells moderate experimental autoimmune uveitis by dynamic regulating Th17 and Breg cells response. J Tissue Eng Regen Med. 16:26–35. 2022. View Article : Google Scholar | |
Franquesa M, Mensah FK, Huizinga R, Strini T, Boon L, Lombardo E, DelaRosa O, Laman JD, Grinyó JM, Weimar W, et al: Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells. Stem Cells. 33:880–891. 2015. View Article : Google Scholar | |
Luk F, de Witte SF, Korevaar SS, Roemeling-van Rhijn M, Franquesa M, Strini T, van den Engel S, Gargesha M, Roy D, Dor FJ, et al: Inactivated mesenchymal stem cells maintain immunomodulatory capacity. Stem Cells Dev. 25:1342–1354. 2016. View Article : Google Scholar : PubMed/NCBI | |
Ye L, Zhang Q, Cheng Y, Chen X, Wang G, Shi M, Zhang T, Cao Y, Pan H, Zhang L, et al: Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion. J Immunother Cancer. 6:1452018. View Article : Google Scholar : | |
Blache U, Tretbar S, Koehl U, Mougiakakos D and Fricke S: CAR T cells for treating autoimmune diseases. RMD Open. 9:e0029072023. View Article : Google Scholar : PubMed/NCBI | |
Cremoni M, Massa F and Sicard A: Overcoming barriers to widespread use of CAR-Treg therapy in organ transplant recipients. HLA. 99:565–572. 2022. View Article : Google Scholar : PubMed/NCBI | |
Calderón-Gómez E and Fillatreau S: Utilization of a lentiviral system for the generation of B cells with regulatory properties. Methods Mol Biol. 1190:105–113. 2014. View Article : Google Scholar : PubMed/NCBI | |
Alonso-Guallart P, Llore N, Lopes E, Kofman SB, Ho SH, Stern J, Pierre G, Bruestle K, Tang Q, Sykes M and Griesemer A: CD40L-stimulated B cells for ex-vivo expansion of polyspecific non-human primate regulatory T cells for translational studies. Clin Exp Immunol. 203:480–492. 2021. View Article : Google Scholar | |
Abreu TR, Fonseca NA, Gonçalves N and Moreira JN: Current challenges and emerging opportunities of CAR-T cell therapies. J Control Release. 319:246–261. 2020. View Article : Google Scholar : PubMed/NCBI | |
Miliotou AN and Papadopoulou LC: CAR T-cell Therapy: A New Era in Cancer Immunotherapy. Curr Pharm Biotechnol. 19:5–18. 2018. View Article : Google Scholar : PubMed/NCBI | |
Wilhelm A, Chambers D, Müller F, Bozec A, Grieshaber-Bouyer R, Winkler T, Mougiakakos D, Mackensen A, Schett G and Krönke G: Selective CAR T cell-mediated B cell depletion suppresses IFN signature in SLE. JCI Insight. 9:e1794332024. View Article : Google Scholar : PubMed/NCBI | |
Wagner JC, Ronin E, Ho P, Peng Y and Tang Q: Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival. Am J Transplant. 22:2237–2245. 2022. View Article : Google Scholar : PubMed/NCBI | |
Mansourabadi AH, Mohamed Khosroshahi L, Noorbakhsh F and Amirzargar A: Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells. Int Immunopharmacol. 97:1076692021. View Article : Google Scholar : PubMed/NCBI | |
Montgomery RA, Tatapudi VS, Leffell MS and Zachary AA: HLA in transplantation. Nat Rev Nephrol. 14:558–570. 2018. View Article : Google Scholar : PubMed/NCBI | |
Bodis G, Toth V and Schwarting A: Role of human leukocyte antigens (HLA) in autoimmune diseases. Rheumatol Ther. 5:5–20. 2018. View Article : Google Scholar : PubMed/NCBI | |
Boardman DA, Philippeos C, Fruhwirth GO, Ibrahim MA, Hannen RF, Cooper D, Marelli-Berg FM, Watt FM, Lechler RI, Maher J, et al: Expression of a chimeric antigen receptor specific for donor HLA class I enhances the potency of human regulatory T cells in preventing human skin transplant rejection. Am J Transplant. 17:931–943. 2017. View Article : Google Scholar | |
González-Galarza FF, Takeshita LY, Santos EJ, Kempson F, Maia MH, da Silva AL, Teles e Silva AL, Ghattaoraya GS, Alfirevic A, Jones AR and Middleton D: Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res. 43(Database Issue): D784–D788. 2015. View Article : Google Scholar : | |
Ajith A, Mamouni K, Musa A, Horuzsko DD, Gani I, Mulloy LL and Horuzsko A: IL-10-producing memory B regulatory cells as a novel target for HLA-G to prolong human kidney allograft survival. Hum Immunol. 84:366–373. 2023. View Article : Google Scholar : PubMed/NCBI | |
Bottomley MJ, Brook MO, Shankar S, Hester J and Issa F: Towards regulatory cellular therapies in solid organ transplantation. Trends Immunol. 43:8–21. 2022. View Article : Google Scholar | |
McNee A, Kannan A, Jull P and Shankar S: Expanding human breg for cellular therapy in transplantation: Time for translation. Transplantation. Oct 23–2024.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI | |
Geissler EK and Hutchinson JA: Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipients. Curr Opin Organ Transplant. 18:408–415. 2013. View Article : Google Scholar : PubMed/NCBI | |
Chu Z, Zou W, Xu Y, Sun Q and Zhao Y: The regulatory roles of B cell subsets in transplantation. Expert Rev Clin Immunol. 14:115–125. 2018. View Article : Google Scholar : PubMed/NCBI | |
Mohib K, Cherukuri A and Rothstein DM: Regulatory B cells and transplantation: Almost prime time? Curr Opin Organ Transplant. 23:524–532. 2018. View Article : Google Scholar : PubMed/NCBI | |
Chesneau M, Michel L, Degauque N and Brouard S: Regulatory B cells and tolerance in transplantation: From animal models to human. Front Immunol. 4:4972013. View Article : Google Scholar | |
Silva HM, Takenaka MC, Moraes-Vieira PM, Monteiro SM, Hernandez MO, Chaara W, Six A, Agena F, Sesterheim P, Barbé-Tuana FM, et al: Preserving the B-cell compartment favors operational tolerance in human renal transplantation. Mol Med. 18:733–743. 2012. View Article : Google Scholar : PubMed/NCBI | |
Clatworthy MR, Watson CJ, Plotnek G, Bardsley V, Chaudhry AN, Bradley JA and Smith KG: B-cell-depleting induction therapy and acute cellular rejection. N Engl J Med. 360:2683–2685. 2009. View Article : Google Scholar : PubMed/NCBI | |
Veh J, Ludwig C, Schrezenmeier H and Jahrsdörfer B: Regulatory B cells-immunopathological and prognostic potential in humans. Cells. 13:3572024. View Article : Google Scholar : PubMed/NCBI | |
Le Huu D, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, Tedder TF and Fujimoto M: Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood. 121:3274–3283. 2013. View Article : Google Scholar : PubMed/NCBI | |
Fang T, Koo TY, Lee JG, Jang JY, Xu Y, Hwang JH, Park S, Yan JJ, Ryu JH, Ryu YM, et al: Anti-CD45RB antibody therapy attenuates renal ischemia-reperfusion injury by inducing regulatory B cells. J Am Soc Nephrol. 30:1870–1885. 2019. View Article : Google Scholar : PubMed/NCBI | |
Matsushita T: Regulatory and effector B cells: Friends or foes? J Dermatol Sci. 93:2–7. 2019. View Article : Google Scholar | |
Zhao H, Feng R, Peng A, Li G and Zhou L: The expanding family of noncanonical regulatory cell subsets. J Leukoc Biol. 106:369–383. 2019. View Article : Google Scholar : PubMed/NCBI | |
Natarajan P, Singh A, McNamara JT, Secor ER, Guernsey LA, Thrall RS and Schramm CM: Regulatory B cells from hilar lymph nodes of tolerant mice in a murine model of allergic airway disease are CD5+, express TGF-β, and co-localize with CD4+Foxp3+ T cells. Mucosal Immunol. 5:691–701. 2012. View Article : Google Scholar : PubMed/NCBI | |
Khalil MI, Gurski CJ, Dittel LJ, Neu SD and Dittel BN: Discovery and Function of B-Cell IgD Low (BDL) B Cells in Immune Tolerance. J Mol Biol. 433:1665842021. View Article : Google Scholar | |
Agbogan VA, Gastineau P, Tejerina E, Karray S and Zavala F: CpG-Activated regulatory B-cell progenitors alleviate murine graft-versus-host-disease. Front Immunol. 13:7905642022. View Article : Google Scholar : PubMed/NCBI | |
Lal G, Kulkarni N, Nakayama Y, Singh AK, Sethi A, Burrell BE, Brinkman CC, Iwami D, Zhang T, Hehlgans T and Bromberg JS: IL-10 from marginal zone precursor B cells controls the differentiation of Th17, Tfh and Tfr cells in transplantation tolerance. Immunol Lett. 170:52–63. 2016. View Article : Google Scholar : PubMed/NCBI | |
Bao Y and Xiu DR: Adaptive transfer of B10 cells: A novel therapy for chronic rejection after solid organ transplantation. Med Hypotheses. 81:101–103. 2013. View Article : Google Scholar : PubMed/NCBI | |
Gorczynski RM, Farrokhi K, Gorczynski C, Sadozai H, Zhu F and Khatri I: Importance of B cells to development of regulatory T cells and prolongation of tissue allograft survival in recipients receiving autologous bone marrow transplantation. Immunology. 154:465–475. 2018. View Article : Google Scholar : PubMed/NCBI | |
Lindner S, Dahlke K, Sontheimer K, Hagn M, Kaltenmeier C, Barth TF, Beyer T, Reister F, Fabricius D, Lotfi R, et al: Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res. 73:2468–2479. 2013. View Article : Google Scholar : PubMed/NCBI | |
Horikawa M, Weimer ET, DiLillo DJ, Venturi GM, Spolski R, Leonard WJ, Heise MT and Tedder TF: Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice. J Immunol. 190:1158–1168. 2013. View Article : Google Scholar : PubMed/NCBI |